Ball v. Mallinkrodt Chemical Works

381 S.W.2d 563, 53 Tenn. App. 218, 19 A.L.R. 3d 813, 1964 Tenn. App. LEXIS 96
CourtCourt of Appeals of Tennessee
DecidedJanuary 16, 1964
StatusPublished
Cited by22 cases

This text of 381 S.W.2d 563 (Ball v. Mallinkrodt Chemical Works) is published on Counsel Stack Legal Research, covering Court of Appeals of Tennessee primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Ball v. Mallinkrodt Chemical Works, 381 S.W.2d 563, 53 Tenn. App. 218, 19 A.L.R. 3d 813, 1964 Tenn. App. LEXIS 96 (Tenn. Ct. App. 1964).

Opinion

McAMIS, P.J.

Mrs. Lorene Ball brought suit against Dr. Jesse Adams, a vascular surgeon, charging malpractice in the performance of a test known as trans-lumbar aortogram by the injection of Urokon 70, manufactured and sold by the defendant Mallinkrodt Chemical Works. Her husband sued in a separate action for loss of services and medical expenses incurred in the treatment of Mrs. Ball. The two cases were tried together.

The Court refused to allow the case to go to the jury as to certain charges contained in the declarations but, as to others, the motion for a directed verdict was overruled. The jury returned a verdict for both defendants in which the Court concurred. From the judgment dis *222 missing both suits, plaintiffs have appealed and assigned errors.

As to Dr. Adams, the Court submitted to the jury the charge that, in performing the aortogram, he negligently selected Urokon 70, a toxic, unsafe and unsuitable substance, as the contrast agent for taking X-ray pictures of the renal arteries and that in obtaining Mrs. Ball’s consent to the procedure he failed sufficiently to advise her of the danger of paralysis and other possible serious consequences.

The court submitted to the jury as to Mallinkrodt Chemical Works the charge that in manufacturing and selling Urokon 70 it knew or should have known that it was an unsuitable and unsafe contrast agent for making aortograms and thus breached an implied warranty of fitness and was guilty of proximate negligence.

In January, 1960, Mrs. Ball consulted Dr. David McCallie for symptoms of high blood pressure which was found upon examination by Dr. McCallie to be 240/150. On his recommendation she was hospitalized. Dr. Mc-Callie treated her for this condition without success and without a determination of its cause at intervals until June 22, 1961. At that time Dr. McCallie advised her that it might be possible to determine by means of the diagnostic procedure known as translumbar aortogram whether, as is sometimes the case, her high blood pressure was being caused by a partial blocking of the renal arteries leading to the kidneys. Dr. Adams, a specialist in this field, was called in to perform the test.

As we understand, this procedure consists of passing a flexible tube syringe through the patient’s back and against the wall of the aorta, the large artery leading *223 off in an upward direction from the heart. A long needle is then inserted within the tube and forced through the lumen or outer wall of the aorta. The contrast agent is then forced through the needle into the aorta and passes very rapidly into the renal arteries leading down to the kidneys, permitting the taking of X-ray pictures of these arteries to show any existing obstructions.

Almost immediately after the injection of Urokon 70 by Dr. Adams, Mrs. Ball experienced the most excruciating pain in her chest and abdomen. This was shortly followed by a numbness and paralysis of both legs, one of which continues to be paralyzed and almost, if not entirely, useless. The X-ray pictures taken during the test show that some of the solution escaped outside the aorta. It is the insistence of plaintiffs that it then migrated to the spinal cord causing damage which resulted in paralysis of Mrs. Ball’s leg and some impairment of nerves controlling bowel and kidney action.

Conceding that Mrs. Ball suffered these injuries as the result of the use of Urokon 70, defendants insist that, in spite of the utmost skill and care on the part of the surgeon making the test, the escape of dye outside the aorta occurs in about five to ten percent of the cases and that even where this occurs the extravasated dye is absorbed by the system without harmful effect except that it causes the patient severe pain for two or three hours. It is defendants’ theory and insistence that the Urokon 70 which caused the damage to Mrs. Ball’s spinal cord passed through the needle into the aorta and thence into the arteries feeding the spinal cord and that this is a danger inherent in the test since it occurs in spite of all precautions which can be taken in about one per cent *224 of all cases, no mattér what contrast agent is nsed or how skillful the surgeon may he.

Considering first plaintiffs’ insistence that there is no evidence to sustain a finding that defendants were guilty of no negligence, we find that from 1954 until and including 1960, when the test on Mrs. Ball was made, Urokon 70 was the contrast agent chosen by at least half the surgeons performing aortograms in the United States. This choice was made despite the existence of other available agents considered by some to be less toxic because the use of Urokon 70 permitted the taking of better X-rays of the renal arteries. There is material evidence, however, that no contrast agent is completely safe.

Some of the foremost practicing and teaching surgeons testified that, knowing its toxic nature, they have used Urokon 70 because it gives the best picture and, since the test is a severe and somewhat dangerous procedure used only in extreme cases when all else has failed, it is deemed unwise to have the patient undergo the test without a reasonable expectation that a satisfactory picture can be obtained.

It is well settled that where the treatment or procedure is one of choice among competent physicians a physician can not be held guilty of malpractice in selecting the one which, according to his best judgment, is best suited to the patient’s needs. The principle is so well established that a review o,f the authorities would be superfluous. See, however, Quinley v. Cocke, 183 Tenn. 428, 192 S.W.(2d) 992; Gresham v. Ford, 192 Tenn. 310, 241 S.W.(2d) 408; Floyd v. Walls, 26 Tenn.App. 151, 168 S.W.(2d) 602.

*225 There was abundant, evidence from which the jury might conclude that Dr. Adams in the exercise of his best judgment chose the proper contrast agent for making the test and that its use is sanctioned and approved by competent medical authorities.

We are also of opinion under the same evidence it was for the jury to say whether there was a breach of an implied warranty of fitness or negligence on the part of Mallihkrodt Chemical Works in making Urokon 70 available for use by competent and skilled surgeons in the performance of aortograms.

As to Dr. Adams, it is insisted the Court erred in refusing to submit to the jury the insistence of plaintiffs that he negligently used 24 c.c. of Urokon 70, negligently injected the dye outside the aorta, failed to take a preliminary X-ray known as a scout film to show the position of the needle before making the injection, and negligently failed to use a safer medium.

We think the Court ruled correctly as to all of these issues. Although the manufacturer’s brochure stated that the proper amount was 15 c.c.s, Dr. Adams testified that he used 24 c.c.s because he thought it necessary in order to get a good picture. There is competent medical testimony that according to the best usage and practice 24 c.c.s is within the permissible range, bearing in mind that the sole purpose of the test is to get a satisfactory view of the renal arteries.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Darrell Massingale v. Yung Gil Lee, P.C.
Court of Appeals of Tennessee, 2005
Harden v. Danek Medical, Inc.
985 S.W.2d 449 (Court of Appeals of Tennessee, 1998)
Shadrick v. Coker
963 S.W.2d 726 (Tennessee Supreme Court, 1998)
Housh v. Morris
818 S.W.2d 39 (Court of Appeals of Tennessee, 1991)
Wasfi v. Chaddha
588 A.2d 204 (Supreme Court of Connecticut, 1991)
Holley v. Burroughs Wellcome Co.
330 S.E.2d 228 (Court of Appeals of North Carolina, 1985)
Truan v. Smith
578 S.W.2d 73 (Tennessee Supreme Court, 1979)
Sard v. Hardy
367 A.2d 525 (Court of Special Appeals of Maryland, 1976)
McDaniel v. McNeil Laboratories, Inc.
241 N.W.2d 822 (Nebraska Supreme Court, 1976)
Lois Sawyer and David Sawyer v. Methodist Hospital
522 F.2d 1102 (Sixth Circuit, 1975)
Sawyer v. Methodist Hospital of Memphis
383 F. Supp. 563 (W.D. Tennessee, 1974)
Rickett v. Hayes
511 S.W.2d 187 (Supreme Court of Arkansas, 1974)
Nishi v. Hartwell
473 P.2d 116 (Hawaii Supreme Court, 1970)
Barbara Campbell v. Peter Oliva, M.D.
424 F.2d 1244 (Sixth Circuit, 1970)
Dunham v. Wright
302 F. Supp. 1108 (M.D. Pennsylvania, 1969)

Cite This Page — Counsel Stack

Bluebook (online)
381 S.W.2d 563, 53 Tenn. App. 218, 19 A.L.R. 3d 813, 1964 Tenn. App. LEXIS 96, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ball-v-mallinkrodt-chemical-works-tennctapp-1964.